Modulators of RabGGT and methods of use thereof
The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LYNCH MARK O'BRIAN CAROL L KINDT RACHEL M MANNE VEERASWAMY COSTA MICHAEL R ZHANG HAI GUANG HUNG TAK LAING NAOMI FITZGERALD KEVIN LOMBARDO LOUIS J MAXWELL MARK E ROSS-MACDONALD PETRA B BROWN KATHERINE S STOUCH TERRY LEE JAE MOON CARROLL PAMELA LACKNER MARK R |
| description | The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2004142888A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2004142888A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2004142888A13</originalsourceid><addsrcrecordid>eNrjZND3zU8pzUksyS8qVshPUwhKTHJ3D1FIzEtRyE0tychPAYuWFqcqlGSkFqXmp_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDAxNDEyMLCwtHQ2PiVAEAgDkrIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modulators of RabGGT and methods of use thereof</title><source>esp@cenet</source><creator>LYNCH MARK ; O'BRIAN CAROL L ; KINDT RACHEL M ; MANNE VEERASWAMY ; COSTA MICHAEL R ; ZHANG HAI GUANG ; HUNG TAK ; LAING NAOMI ; FITZGERALD KEVIN ; LOMBARDO LOUIS J ; MAXWELL MARK E ; ROSS-MACDONALD PETRA B ; BROWN KATHERINE S ; STOUCH TERRY ; LEE JAE MOON ; CARROLL PAMELA ; LACKNER MARK R</creator><creatorcontrib>LYNCH MARK ; O'BRIAN CAROL L ; KINDT RACHEL M ; MANNE VEERASWAMY ; COSTA MICHAEL R ; ZHANG HAI GUANG ; HUNG TAK ; LAING NAOMI ; FITZGERALD KEVIN ; LOMBARDO LOUIS J ; MAXWELL MARK E ; ROSS-MACDONALD PETRA B ; BROWN KATHERINE S ; STOUCH TERRY ; LEE JAE MOON ; CARROLL PAMELA ; LACKNER MARK R</creatorcontrib><description>The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity.</description><edition>7</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040722&DB=EPODOC&CC=US&NR=2004142888A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040722&DB=EPODOC&CC=US&NR=2004142888A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LYNCH MARK</creatorcontrib><creatorcontrib>O'BRIAN CAROL L</creatorcontrib><creatorcontrib>KINDT RACHEL M</creatorcontrib><creatorcontrib>MANNE VEERASWAMY</creatorcontrib><creatorcontrib>COSTA MICHAEL R</creatorcontrib><creatorcontrib>ZHANG HAI GUANG</creatorcontrib><creatorcontrib>HUNG TAK</creatorcontrib><creatorcontrib>LAING NAOMI</creatorcontrib><creatorcontrib>FITZGERALD KEVIN</creatorcontrib><creatorcontrib>LOMBARDO LOUIS J</creatorcontrib><creatorcontrib>MAXWELL MARK E</creatorcontrib><creatorcontrib>ROSS-MACDONALD PETRA B</creatorcontrib><creatorcontrib>BROWN KATHERINE S</creatorcontrib><creatorcontrib>STOUCH TERRY</creatorcontrib><creatorcontrib>LEE JAE MOON</creatorcontrib><creatorcontrib>CARROLL PAMELA</creatorcontrib><creatorcontrib>LACKNER MARK R</creatorcontrib><title>Modulators of RabGGT and methods of use thereof</title><description>The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND3zU8pzUksyS8qVshPUwhKTHJ3D1FIzEtRyE0tychPAYuWFqcqlGSkFqXmp_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDAxNDEyMLCwtHQ2PiVAEAgDkrIA</recordid><startdate>20040722</startdate><enddate>20040722</enddate><creator>LYNCH MARK</creator><creator>O'BRIAN CAROL L</creator><creator>KINDT RACHEL M</creator><creator>MANNE VEERASWAMY</creator><creator>COSTA MICHAEL R</creator><creator>ZHANG HAI GUANG</creator><creator>HUNG TAK</creator><creator>LAING NAOMI</creator><creator>FITZGERALD KEVIN</creator><creator>LOMBARDO LOUIS J</creator><creator>MAXWELL MARK E</creator><creator>ROSS-MACDONALD PETRA B</creator><creator>BROWN KATHERINE S</creator><creator>STOUCH TERRY</creator><creator>LEE JAE MOON</creator><creator>CARROLL PAMELA</creator><creator>LACKNER MARK R</creator><scope>EVB</scope></search><sort><creationdate>20040722</creationdate><title>Modulators of RabGGT and methods of use thereof</title><author>LYNCH MARK ; O'BRIAN CAROL L ; KINDT RACHEL M ; MANNE VEERASWAMY ; COSTA MICHAEL R ; ZHANG HAI GUANG ; HUNG TAK ; LAING NAOMI ; FITZGERALD KEVIN ; LOMBARDO LOUIS J ; MAXWELL MARK E ; ROSS-MACDONALD PETRA B ; BROWN KATHERINE S ; STOUCH TERRY ; LEE JAE MOON ; CARROLL PAMELA ; LACKNER MARK R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2004142888A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LYNCH MARK</creatorcontrib><creatorcontrib>O'BRIAN CAROL L</creatorcontrib><creatorcontrib>KINDT RACHEL M</creatorcontrib><creatorcontrib>MANNE VEERASWAMY</creatorcontrib><creatorcontrib>COSTA MICHAEL R</creatorcontrib><creatorcontrib>ZHANG HAI GUANG</creatorcontrib><creatorcontrib>HUNG TAK</creatorcontrib><creatorcontrib>LAING NAOMI</creatorcontrib><creatorcontrib>FITZGERALD KEVIN</creatorcontrib><creatorcontrib>LOMBARDO LOUIS J</creatorcontrib><creatorcontrib>MAXWELL MARK E</creatorcontrib><creatorcontrib>ROSS-MACDONALD PETRA B</creatorcontrib><creatorcontrib>BROWN KATHERINE S</creatorcontrib><creatorcontrib>STOUCH TERRY</creatorcontrib><creatorcontrib>LEE JAE MOON</creatorcontrib><creatorcontrib>CARROLL PAMELA</creatorcontrib><creatorcontrib>LACKNER MARK R</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LYNCH MARK</au><au>O'BRIAN CAROL L</au><au>KINDT RACHEL M</au><au>MANNE VEERASWAMY</au><au>COSTA MICHAEL R</au><au>ZHANG HAI GUANG</au><au>HUNG TAK</au><au>LAING NAOMI</au><au>FITZGERALD KEVIN</au><au>LOMBARDO LOUIS J</au><au>MAXWELL MARK E</au><au>ROSS-MACDONALD PETRA B</au><au>BROWN KATHERINE S</au><au>STOUCH TERRY</au><au>LEE JAE MOON</au><au>CARROLL PAMELA</au><au>LACKNER MARK R</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modulators of RabGGT and methods of use thereof</title><date>2004-07-22</date><risdate>2004</risdate><abstract>The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2004142888A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
| title | Modulators of RabGGT and methods of use thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A56%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LYNCH%20MARK&rft.date=2004-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2004142888A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |